News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 1240
- Sources here
- 19
- Companies here
- 18
Active search
1240 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Earnings call transcript: Companhia Siderúrgica Nacional posts Q2 2026 beat By Investing.com
Companhia Siderúrgica Nacional (CSN) reported stronger-than-expected Q2 2026 results, exceeding Wall Street forecasts for both earnings and revenue, driven by improved performance across its diversified segments including steel, mining, cement, logistics, and energy. The company also achieved positive free cash flow and a modest …
QuickLogic (QUIK) Stock Price Faces Valuation Reset Despite Narrower Losses
QuickLogic (QUIK) stock dropped approximately 4% despite narrower losses in its Q2 2026 earnings report, indicating a valuation reset by investors. The company's revenue increased, and net loss narrowed, but delays in key contracts and the removal of an Intel ASIC design from its …
Companhia Siderúrgica Nacional 2026 Q2 - Results - Earnings Call Presentation (NYSE:SID) 2026-08-13
Companhia Siderúrgica Nacional (SID) released its Q2 2026 earnings call presentation on August 13, 2026. The company reported an EPS of -$0.12, missing estimates by $0.09, and revenue of $2.18 billion, which beat estimates by $29.47 million and represented a 12.86% year-over-year increase. The …
STAAR Surgical (STAA) Stock Price Shrugs Off Profit Rebound As China Dominates
STAAR Surgical reported a strong Q2 2026, returning to profit with $8.1 million in net income and $93.5 million in sales, largely driven by significant growth in China. Despite these positive results, the stock price barely moved, reflecting investor concerns about the company's heavy …
Sagicor Financial Co Ltd (SGCFF) (Q2 2026) Earnings Call Highlights: Core Earnings Surge to ...
This article first appeared on GuruFocus. Core Earnings to Shareholders: $34 million in Q2 2026, up from $25 million in Q1 2026. Net Income to Shareholders: $87 million, benefiting from favorable interest rate movements and strong equity markets. Annualized Core ROE: 13.6% for Q2, …
Jefferies cuts STAAR Surgical stock price target on estimate update
Jefferies has lowered its price target for STAAR Surgical (NASDAQ:STAA) to $28 from $29, while maintaining a Hold rating, following the company's second-quarter 2026 results. STAAR Surgical reported Q2 revenue of $93.5 million, beating consensus estimates, with strong China sales, but missed earnings per …
Lightwave Logic (NASDAQ:LWLG) Stock Price Down 7% - What's Next?
Lightwave Logic (NASDAQ:LWLG) shares dropped 7% during mid-day trading to $7.45, falling below its 50-day and 200-day moving averages. Analyst sentiment is predominantly negative, with several firms reiterating "Sell" ratings due to weak financial performance, including a quarterly loss of $0.04 per share and …
Earnings call transcript: Companhia Siderúrgica Nacional posts Q2 2026 beat
Companhia Siderúrgica Nacional (CSN) reported stronger-than-expected Q2 2026 results, exceeding Wall Street forecasts for both earnings and revenue, driven by improved performance across its diversified segments including steel, mining, cement, logistics, and energy. The company also achieved positive free cash flow and a modest …
AbCellera Biologics Inc. • Robinhood Token (ABCL) Price Prediction for 2026 to 2031
This article provides price predictions for AbCellera Biologics Inc. • Robinhood Token (ABCL) from 2026 to 2045, based on Bybit AI's analysis of user-driven Consensus Ratings and historical patterns. It forecasts a positive trend for ABCL's price, with significant potential ROI over the years, …
Can Asceniv Help ADMA Stock Combat IG Market Challenges?
ADMA Biologics ADMA is a U.S.-based commercial-stage biopharmaceutical company focused on developing, manufacturing and marketing specialty biologics for immunodeficient patients and individuals at risk of certain infectious diseases. The company currently markets three FDA-approved plasma-derived biologics: Asceniv (immune globulin intravenous – slra 10% liquid) …
Lightwave Logic (LWLG) Adds Stage 3 Customers, Is The Upside Already Priced In?
Lightwave Logic (LWLG) has expanded its Stage 3 customer programs, including a Fortune Global 500 client, leading to significant recent stock price gains. Despite a strong year-to-date return of 118.9%, the company's valuation against a narrative-assigned fair value of $74.10 suggests it might still …
Companhia Siderurgica Nacional S.A. Stock 12‑Month Price Target Raised to $1.54, Implies 78% Upside
The 12-month average price target for Companhia Siderurgica Nacional S.A. (CSNA3) stock has been raised from $1.53 to $1.54 by 11 analysts, with a potential upside of 78% based on the August 12 closing price. Despite the increased price target, the consensus rating for …
STAAR Surgical Company Q2 2026 Earnings Call Summary
STAAR Surgical reported record first-half revenue, driven by the successful launch of EVO Plus in China, which helped gain market share despite a challenging refractive market. The company is strategically shifting to a platform approach, with plans for new product development and a transition …
STAAR Surgical Company Stock 12‑Month Price Target Cut to $28.89, Implies 14% Upside
STAAR Surgical Company's average 12-month price target has been reduced to $28.89 from $29.33, according to estimates from 9 analysts. This updated target suggests a potential upside of approximately 14% based on the August 12 closing price. The consensus rating for the stock remains …
Piper Sandler reiterates Neutral on STAAR Surgical stock at $33
Piper Sandler reiterated a Neutral rating on STAAR Surgical (NASDAQ:STAA) with a $33.00 price target, following the company's second-quarter results. While STAAR Surgical's China business exceeded expectations, generating $52.3 million in revenue, the company missed revenue expectations in other key regions like the United …
STAAR Surgical (NASDAQ:STAA) Price Target Lowered to $37.00 at Wedbush
Wedbush has lowered its price target for STAAR Surgical (NASDAQ:STAA) to $37.00 from $40.00 but maintained an "outperform" rating, indicating a potential upside of 45.61%. Despite this, analyst sentiment is mixed, with an average "hold" rating and a consensus price target of $26.61. The …
Intuitive Surgical (ISRG) Backs Long-Term Moat Amid Near-Term Volatility
TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve …
Alpha Metallurgical (AMR): Mohnish Pabrai discloses 603,358-share, 4.76% position
Mohnish Pabrai has disclosed a beneficial ownership of 603,358 shares, representing a 4.76% stake, in Alpha Metallurgical Resources Inc. (AMR). This position is held through client and nonprofit accounts managed by Dalal Street LLC and Dhandho Funds LLC, where Pabrai acts as portfolio manager …
STAAR Surgical: China Generates More Than Half Of Q2 Revenue As Total Sales Jump 111%
STAAR Surgical reported a 111% year-over-year jump in Q2 2026 net sales to $93.5 million, with China contributing over half of this revenue at $52.3 million. The company saw significant profitability improvements, including a gross margin increase to 74.5% and net income of $8.1 …